Reference to Primary Literature
- Caggiano TJ, Zask A, Bex F Ann. Rev. 1991 26 20.
Reference to Patent Literature
- Morishita Jintan Co Ltd, JP03086831.
- Henning Berlin GmbH Chemie-und Pharmawerk, EP-461290-A.
- Nippon Zoki Pharmaceutical Co Ltd, EP-42454-A.
- Kanebo Ltd, JP03048627.
- Kanebo Ltd, JP03081228.
- Otsuka Pharm Co Ltd, JP03058940.
- Takeda Chem Ind Ltd, EP-449196-A.
- Takeda Chem Ind Ltd, JP03130216.
- Adir et Cie, EP-415850-A.
- Adir et Cie, EP-445025-A.
- Yoshitomi Pharm Ind Ltd, WO9203427.
- Toray Industries Inc, WO9102737.
- American Home Products Corp, EP-434405-A.
- Research Corp Technologies Inc, WO9114430.
- Research Corp Technologies Inc, WO9114682.
- Research Corp Technologies Inc, WO9114683.
- Pfizer Inc, US5008283.
- Pfizer Inc, US5064851.
- Pfizer Inc, EP-425109.
- University of Pennsylvania, US5070108.
- Green Cross Corp, EP-4606900A.
- Merck & Co Inc, EP-449405-A.
- Ortho Pharm Corp, EP-474374-A.
- Teijin Ltd, JP03099022.
- Ciba-Geigy, EP-436469-A.
- Forssmann W G Franz F Schulz-Knappe P, DE3935738.
- National Institute of Health, US612674.
- Perstorp A B, WO9109601.
- Perstorp A B, WO9109604.
- Chiesi Farmaceutici SpA, WO9114429.
- Astra A B, WO9106296.
- Rowett Research Institute, WO9110141.